Advanced Enzyme Technologies Limited (ADVENZYMES) — Board Meeting | 3 July 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Advanced Enzyme Technologies Limited announced that its 37th Annual General Meeting will be held on July 31, 2026, via video conference, with a record date of July 24, 2026, to determine dividend eligibility on the proposed final dividend of ₹1.35 per share for FY26, to be paid after August 3, 2026, if approved.

📄 View Original Announcement (PDF)

About Advanced Enzyme Technologies Limited (ADVENZYMES)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,071.34 Cr P/E: 24.1 ROE: 10.3% ROCE: 13.8%

View full ADVENZYMES stock details →

📡 Get AI alerts when ADVENZYMES files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ADVENZYMES — Free

📊 More ADVENZYMES filings

See all ADVENZYMES filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ADVENZYMES files new disclosures

Track ADVENZYMES filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ADVENZYMES — Free

Free account · 2 AI queries/day